Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): treatment highlights
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Karagiannis (Rhodes, Greece). Late Breaking Abstract - Six years experience of Pirfenidone treatment in IPF patients in Crete: Real life data. 3397

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - Patients with severe eosinophilic asthma benefit from the treatment with Anti-IL-5 Reslizumab – a real life study from Austria Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Long-term (4 years) experience of Nintedanib in IPF patients in Crete: A real life data study Source: International Congress 2018 – Management of idiopathic interstitial pneumonias: established and new treatments Year: 2018 Late Breaking Abstract - Early ICU physiotherapy on SARS-CoV-2 patients: A Spanish experience case series Source: Virtual Congress 2020 – Novel findings in intensive care unit medicine: part 2 Year: 2020 Late Breaking Abstract - Idiopathic Pulmonary Fibrosis – a worldwide review of ‘real’ life’ practice: experience from a treatment feasibility review in 41 countries Source: International Congress 2018 – ILDs: From bench to bedside Year: 2018 Late Breaking Abstract - Real world patient-reported outcomes in asthma across six European countries: the NEWTON study Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Late Breaking Abstract - Initiation of patient enrollment in treatment with BPaL in Ukraine: first intermediate results Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease Year: 2021 Late Breaking Abstract - Early follow-up of hospitalised and non-hospitalised patients with Covid-19 in a Swedish setting Source: Virtual Congress 2021 – Challenges of COVID-19 management at short and long-term Year: 2021 Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients. Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 Late Breaking Abstract - Comparative analysis of effectiveness of Asthma Control Test-guided treatment versus usual care in patients with asthma from China Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Effectiveness evaluation of anti-IgE treatment at 3rd year: Real life Turkey data Source: International Congress 2016 – Asthma points to ponder Year: 2016 Late Breaking Abstract - Asthma control in preschool and subsequent disease remission Source: International Congress 2019 – Asthma and the world Year: 2019 Late Breaking Abstract - Identification of patients with COPD who benefit from benralizumab Source: International Congress 2019 – ALERT: Abstracts Leading to Evolution in Respiratory Medicine Trials: COPD and cough Year: 2019 Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Late Breaking Abstract - Exercise rehabilitation in telemedicine for COVID-19 patients. Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020 Late Breaking Abstract - HRQol and other health related variables of Spanish COPD patients Source: Virtual Congress 2020 – Interesting clinical problems for the respiratory physician Year: 2020 Late Breaking Abstract - Detection of clinical instability by eNose in COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Late Breaking Abstract - Survival and course of lung function in patients with idiopathic pulmonary fibrosis with or without antifibrotic treatment: long-term results of the INSIGHTS-IPF registry Source: International Congress 2019 – Idiopathic pulmonary fibrosis and surroundings Year: 2019 Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study Source: International Congress 2019 – Clinical approach to asthma management Year: 2019 Late Breaking Abstract - Second Souffle: preliminary results from a national survey on the care pathways and quality of life of patients with T2 severe asthma Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 Late Breaking Abstract - Prolonged azithromycin maintenance treatment in patients with COPD, a follow-up of the COLUMBUS trial Source: International Congress 2019 – Blood eosinophils and more in airway diseases Year: 2019